ILD and system medicine

O. Eickelberg (Munich, Germany)

Source: ERS Lung Science Conference 2016
Number: 26

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Eickelberg (Munich, Germany). ILD and system medicine. ERS Lung Science Conference 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD
Source: ERS webinar 2021: Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD
Year: 2021


Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018



Detection of COPD in the setting of occupational medicine
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Palliative medicine services for those with chronic lung disease
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


A personalised medicine approach to ICS use in COPD
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

Personalised medicine through biological subphenotyping of ARDS
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021

From systems biology to P4 medicine: applications in respiratory medicine
Source: Eur Respir Rev, 27 (147) 170110; 10.1183/16000617.0110-2017
Year: 2018



Contemporary challenges for specialist nursing in interstitial lung disease
Source: Breathe, 14 (1) 36; 10.1183/20734735.014917
Year: 2018



Precision medicine in airway diseases: moving to clinical practice
Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017
Year: 2017



Systems medicine advances in interstitial lung disease
Source: Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
Year: 2017



Patient-centred medicine in ILDs: towards a holistic approach
Source: Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway
Year: 2021


Evaluation of the use of e-learning in training management of asthma and COPD in general medicine.
Source: International Congress 2017 – Medical education, web and internet
Year: 2017

Personalised medicine in exacerbations of COPD: the beginnings
Source: Eur Respir J 2012; 40: 1318-1319
Year: 2012


Personalised medicine through ventilator settings: implications of lung morphology in ARDS
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021


Precision medicine in bronchiectasis
Source: Breathe, 17 (4) 210119; 10.1183/20734735.0119-2021
Year: 2021



The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013



Advances in COPD and ILD AJRCCM
Source: International Congress 2016 – AJRCCM Blue Journal in 2016: a joint ERS lunchtime session
Year: 2016


The systems medicine toolbox
Source: International Congress 2017 – Towards personalised medicine for airways diseases: Deep phenotyping using omics approaches will revolutionise future treatment strategies
Year: 2017